NIH Director Page NIH Health Information Page NIH Impact NIH Fact Sheets NIH Social Media and Outreach
EurekAlert! - National Institutes of Health  
LINKS

Resources

 

NIH Main

 

NIH Research News

 

Funded News

 
  For News & Research
  NIH Videos
  eColumn: NIH Research Matters
  NIH News in Health
  NIH Fact Sheets
 
  Additional Resources
  NIH Home Page
 

About NIH

  NIH Health Information
  Pub Med
  MedlinePlus
  Clinical trials.gov
  More News and Events Sources
  NIH News and Events, Special Interest
 
  RSS Feed RSS Feed
  Back to EurekAlert!
 

 


Department of Health and Human Services

News from the National Institutes of Health

Funded News


Key: Meeting M      Journal J      Funder F

Showing releases 3401-3425 out of 3499.

<< < 132 | 133 | 134 | 135 | 136 | 137 | 138 | 139 | 140 > >>

Public Release: 6-Nov-2013
Cancer
Prognostic value of baseline HRQOL for survival for 11 types of cancer pointed out by EORTC study
Results of an EORTC study published in Cancer point out the prognostic value of baseline recorded health-related quality of life for survival for eleven types of cancer: brain, breast, colorectal, esophageal, head and neck, lung, melanoma, ovarian, pancreatic, prostate, and testicular cancer. For each cancer site, at least one health-related quality of life parameter provided additional prognostic information over and above the clinical and sociodemographic variables.
Pfizer Foundation, European Organisation for Research and Treatment of Cancer Charitable Trust, NIH/National Cancer Institute

Contact: John Bean
john.bean@eortc.be
European Organisation for Research and Treatment of Cancer

Public Release: 6-Nov-2013
Lancet Oncology
Long term results of EORTC trial for patients with resectable liver metastases from colorectal cancer
Long term results of the randomized phase III EORTC intergroup trial 40983 were recently reported in The Lancet Oncology. The observed 4.1 percent difference in overall survival at five years for patients with initially resectable liver metastases from colorectal cancer was not significant for perioperative chemotherapy with FOLFOX4 (folinic acid, fluorouracil, and oxaliplatin) compared with surgery alone. The authors conclude that perioperative chemotherapy with FOLFOX4 should remain the reference treatment for this population of patients.
Sanofi -Aventis, NIH/National Cancer Institute, Norwegian and Swedish Cancer Societies, Cancer Research UK, Ligue Nationale Contre le Cancer

Contact: John Bean
john.bean@eortc.be
European Organisation for Research and Treatment of Cancer

Public Release: 6-Nov-2013
Nature
RNA controls splicing during gene expression, further evidence of 'RNA world' origin in modern life
RNA is the key functional component of spliceosomes, molecular machines that control how genes are expressed, report scientists from the University of Chicago online, Nov. 6 in Nature. The discovery establishes that RNA, not protein, is responsible for catalyzing this fundamental biological process and enriches the hypothesis that life on earth began in a world based solely on RNA.
National Institutes of Health, Chicago Biomedical Consortium

Contact: Kevin Jiang
kevin.jiang@uchospitals.edu
773-795-5227
University of Chicago Medical Center

Public Release: 6-Nov-2013
Nature
New study identifies signs of autism in the first months of life
Researchers have identified signs of autism present in the first months of life. The researchers followed babies from birth until 3 years of age, using eye-tracking technology, to measure the way infants look at and respond to social cues. Infants later diagnosed with autism showed declining attention to the eyes of other people, from the age of 2 months onwards.
NIH/National Institute of Mental Health, Simons Foundation, Marcus Foundation, Whitehead Foundation

Contact: Carrie Edwards
carrie.edwards@choa.org
404-785-7253
Emory Health Sciences

Public Release: 6-Nov-2013
Nature
Study uncovers new explanation for infection susceptibility in newborns
Cells that allow helpful bacteria to safely colonize the intestines of newborn infants also suppress their immune systems to make them more vulnerable to infections, according to new research in Nature. To be published online Nov. 6, the study could prompt a major shift in how medicine views the threat of neonatal infections -- and how researchers go about looking for new strategies to stop it, said scientists who conducted the study.
NIH/National Institute of Allergy and Infectious Diseases, NIH/National Heart Lung and Blood Institute

Contact: Nick Miller
nicholas.miller@cchmc.org
513-803-6035
Cincinnati Children's Hospital Medical Center

Public Release: 6-Nov-2013
Journal of Autism and Developmental Disorders
Children who have autism far more likely to have tummy troubles
Children with autism experience gastrointestinal upsets such as constipation, diarrhea and sensitivity to foods six-to-eight times more often than do children who are developing typically, and those symptoms are related to behavioral problems, including social withdrawal, irritability and repetitive behaviors, a new study by researchers at the UC Davis MIND Institute has found.
NIH/National Institute of Environmental Health Sciences, US Environmental Protection Agency

Contact: Phyllis Brown
phyllis.brown@ucdmc.ucdavis.edu
916-734-9023
University of California - Davis Health System

Public Release: 6-Nov-2013
Science Translational Medicine
Monkeys use minds to move 2 virtual arms
In a study led by Duke researchers, monkeys have learned to control the movement of both arms on an avatar using just their brain activity.
National Institutes of Health

Contact: Rachel Harrison
rachel.harrison@duke.edu
919-419-5069
Duke University Medical Center

Public Release: 5-Nov-2013
Nature Physics
Bringing out the best in X-ray crystallography data
Combining components of Rosetta and PHENIX, two successful software programs for creating 3-D structural models of proteins and other biomolecules, Berkeley Lab researchers have created a new method for refining those models and making the best of available experimental data.
US Department of Energy, National Institutes of Health

Contact: Lynn Yarris
lcyarris@lbl.gov
510-486-5375
DOE/Lawrence Berkeley National Laboratory

Public Release: 5-Nov-2013
Proceedings of the National Academy of Sciences
Effects of chronic stress can be traced to your genes
New study suggests "that if you're working for a really bad boss over a long period of time, that experience may play out at the level of gene expression in your immune system," lead researcher says.
National Institutes of Health, MacArthur Foundation, Human Early Learning Partnership, Allergen

Contact: John Sheridan
John.Sheridan@osumc.edu
614-293-3571
Ohio State University

Public Release: 5-Nov-2013
Science Translational Medicine
Breakthrough by Temple researchers could lead to new treatment for heart attack
The stop and start of blood flow to the heart during and after a heart attack causes severe damage to heart cells, reducing their capacity to function and potentially causing their death. But a recent study led by researchers at Temple University School of Medicine suggests that it is possible to limit the extent of that damage using a drug. The findings have significant potential for translation into heart attack patients in a clinical setting.
NIH/National Heart, Lung, and Blood Institute, American Heart Association

Contact: Jeremy Walter
Jeremy.Walter@tuhs.temple.edu
215-707-7882
Temple University Health System

Public Release: 5-Nov-2013
Science Signaling
Temple researchers uncover clues to how existing heart drugs work
Some of the most commonly prescribed drugs for the treatment of heart failure are beta-blockers and nitrates, which help to relax blood vessels and decrease the heart's workload. The drugs were thought to produce those effects through distinct molecular pathways, but according to a new study led by scientists at Temple University School of Medicine, both types of drugs may help the failing heart by counteracting the effects of an enzyme known as GRK2.
National Institutes of Health

Contact: Jeremy Walter
Jeremy.Walter@tuhs.temple.edu
215-707-7882
Temple University Health System

Public Release: 5-Nov-2013
eLife
Study links intestinal bacteria to rheumatoid arthritis
Researchers have linked a species of intestinal bacteria known as Prevotella copri to the onset of rheumatoid arthritis, the first demonstration in humans that the chronic inflammatory joint disease may be mediated in part by specific intestinal bacteria. The new findings by laboratory scientists and clinical researchers in rheumatology at NYU School of Medicine add to the growing evidence that the trillions of microbes in our body play an important role in regulating our health.
National Institutes of Health, Howard Hughes Medical Institute, American Gastroenterological Association

Contact: Craig Andrews
craig.andrews@nyumc.org
212-404-3511
NYU Langone Medical Center / New York University School of Medicine

Public Release: 5-Nov-2013
Brain
Sanders-Brown researchers produce new research on little-understood brain disease
Three recent papers authored by Dr. Peter Nelson and others at the University of Kentucky Sanders-Brown Center on Aging, explore the neuropathology behind a little-understood brain disease, hippocampal sclerosis (known to scientists and clinicians as HS-AGING). HS-AGING, much like Alzheimer's disease, causes symptoms of dementia -- cognitive decline and impaired memory -- in aged persons. Although Alzheimer's disease is probably the most recognized cause of dementia, HS-AGING also causes serious cognitive impairment in older adults.
NIH/National Institute on Aging

Contact: Allison Elliott-Shannon
allison.elliott@uky.edu
University of Kentucky

Public Release: 5-Nov-2013
American Journal of Public Health
Ethical research with minorities
Johns Hopkins bioethicist Nancy Kass is a guest editor of the AJPH special issue taking a comprehensive look at the current ethical landscape of human subjects research with minority populations.
NIH/National Institute on Minority Health and Health Disparities

Contact: Leah Ramsay
lramsay@jhu.edu
202-642-9640
Johns Hopkins Medicine

Public Release: 5-Nov-2013
Molecular Pharmacology
Drug combination therapy causes cancer cells to 'eat themselves'
Results from a recent preclinical study have shown that a new drug combination therapy being developed at Virginia Commonwealth University Massey Cancer Center effectively killed colon, liver, lung, kidney, breast and brain cancer cells while having little effect on noncancerous cells. The results lay the foundation for researchers to plan a future phase 1 clinical trial to test the safety of the therapy in a small group of patients.
NIH/National Cancer Institute

Contact: John Wallace
wallacej@vcu.edu
804-628-1550
Virginia Commonwealth University

Public Release: 5-Nov-2013
JAMA
Interactive computer program helps patients talk with their physician about depression
Patients who used an interactive computer program about depression while waiting to see their primary-care doctor were nearly twice as likely to ask about the condition and significantly more likely to receive a recommendation for antidepressant drugs or a mental-health referral from their physician, according to a new study by researchers at UC Davis.
NIH/National Institute of Mental Health

Contact: Charles Casey
charles.casey@ucdmc.ucdavis.edu
916-734-9048
University of California - Davis Health System

Public Release: 5-Nov-2013
Journal of Neuroscience
Just a few years of early musical training benefits the brain later in life
Older adults who took music lessons as children but haven't actively played an instrument in decades have a faster brain response to a speech sound than individuals who never played an instrument, according to a study appearing Nov. 6 in the Journal of Neuroscience. The finding suggests early musical training has a lasting, positive effect on how the brain processes sound.
National Institutes of Health, Hugh Knowles Center, Northwestern University

Contact: Kat Snodgrass
ksnodgrass@sfn.org
202-962-4090
Society for Neuroscience

Public Release: 5-Nov-2013
ISR Research Center for Group Dynamics Seminar Series on Violence and Aggression
Bad boys: Research predicts whether boys will grow out of it -- or not
Using the hi-tech tools of a new field called neurogenetics and a few simple questions for parents, a University of Michigan researcher is beginning to understand which boys are simply being boys and which may be headed for trouble.
NIH/National Institute on Drug Abuse, NIH/National Institute of Mental Health, NIH/National Heart, Lung and Blood Institute

Contact: Diane Swanbrow
swanbrow@umich.edu
734-647-9069
University of Michigan

Public Release: 5-Nov-2013
Environmental Health Perspectives
Endometriosis risk linked to 2 pesticides
A Fred Hutchinson Cancer Research Center-led study has found that two organochlorine pesticides are associated with an increased risk of endometriosis, a condition that affects up to 10 percent of reproductive-age women.
NIH/Eunice Kennedy Shriver National Institute of Child Health and Human Development, Environmental Protection Agency

Contact: Kristen Woodward
media@fredhutch.org
206-667-2210
Fred Hutchinson Cancer Research Center

Public Release: 4-Nov-2013
Circulation Journal
U-M study: 'Smarter' blood pressure guidelines could prevent many more heart attacks and strokes
Current medical guidelines use a one-size-fits-all treatment approach based on target blood pressure values that leads to some patients being on too many medications and others being on too little.
US Department of Veterans Affairs, National Institutes of Health

Contact: Beata Mostafavi
bmostafa@umich.edu
734-764-2220
University of Michigan Health System

Public Release: 4-Nov-2013
Journal of Neuroscience Methods
A better way to track your every move
Physical activity tracking apps on smartphones are a potentially important tool for doctors who want to collect data and create treatment or intervention plans to improve the health of patients who struggle with activity and movement -- such as those with Parkinson's disease.
National Parkinson Foundation, NIH/National Institute of Neurological Disorders and Stroke

Contact: Erin White
ewhite@northwestern.edu
847-491-4888
Northwestern University

Public Release: 4-Nov-2013
Obesity Week
JAMA
Weighing in: 3 years post-op bariatric surgery patients see big benefits, Pitt study says
For millions of Americans struggling with obesity and considering surgical procedures to achieve weight loss and alleviate obesity-related health complications, a new study adds weight to the health benefits attributed to bariatric surgery.
NIH/National Institutes of Diabetes and Digestive and Kidney Diseases

Contact: Andrea Stanford
stanfordac@upmc.edu
412-647-6190
University of Pittsburgh Schools of the Health Sciences

Public Release: 4-Nov-2013
Molecular Cell
Gene responsible for hereditary cancer syndrome found to disrupt critical growth-regulating pathway
Whitehead Institute scientists report that the gene mutated in the rare hereditary disorder known as Birt-Hogg-Dubé cancer syndrome prevents activation of mTORC1, a critical nutrient-sensing and growth-regulating cellular pathway. This is an unexpected finding, as some cancers keep this pathway turned on to fuel their unchecked growth and expansion. Reconciling these opposing roles may give scientists a new perspective on how cancer cells can distort normal cellular functions to maintain their own harmful ways.
National Institutes of Health, Department of Defense, NIH/National Cancer Institute, David H. Koch Graduate Fellowship Fund, National Science Foundation, Howard Hughes Medical Institute, Jane Coffin Childs Memorial Fund

Contact: Nicole Rura
rura@wi.mit.edu
617-258-6851
Whitehead Institute for Biomedical Research

Public Release: 4-Nov-2013
Proceedings of the National Academy of Sciences
Brain aging is conclusively linked to genes
For the first time in a large study sample, the decline in brain function in normal aging is conclusively shown to be influenced by genes, say researchers from the Texas Biomedical Research Institute in San Antonio and Yale University.
National Institutes of Health

Contact: Joseph Carey
jcarey@txbiomed.org
210-258-9437
Texas Biomedical Research Institute

Public Release: 4-Nov-2013
Nature Genetics
Mutations linked to breast cancer treatment resistance
Researchers at the University of Michigan Comprehensive Cancer Center have identified a type of mutation that develops after breast cancer patients take anti-estrogen therapies. The mutations explain one reason why patients often become resistant to this therapy.
NIH/Clinical Sequencing Exploratory Research Consortium

Contact: Nicole Fawcett
nfawcett@umich.edu
734-764-2220
University of Michigan Health System

Showing releases 3401-3425 out of 3499.

<< < 132 | 133 | 134 | 135 | 136 | 137 | 138 | 139 | 140 > >>

     
   

HOME    DISCLAIMER    PRIVACY POLICY    CONTACT US
Copyright ©2014 by AAAS, the science society.